- Specialty Pharmacies Call for Congress to Act on Pharmacy DIR Fee Reform in Budget Reconciliation Bill Nov 12, 2021 WASHINGTON, DC – As Congress continues to develop and advance budget reconciliation legislation, specialty pharmacies are... read more
- NASP’s Letter to Attorney General Ford regarding the Nevada Board of Pharmacy Reinterpretation of N.R.S. 639.100(1)(a) Nov 04, 2021 View PDF here Dear Attorney General Ford: I write today on behalf of the National Association... read more
- NASP Works with Coalition to Push for Pharmacy DIR Reform Legislation Jun 22, 2021 The National Association of Specialty Pharmacy (NASP) recently joined a coalition of stakeholders to introduce and... read more
- Stakeholders Make Push for Pharmacy DIR Reform Jun 17, 2021 249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price... read more
- Pharmacy Coalition Praises Legislation to Relieve Patients and Pharmacies from Pharmacy DIR Fees May 27, 2021 Urges Congress to pass legislation to reduce patients’ out-of-pocket costs and to prevent pharmacy closures jeopardizing... read more
- NASP Applauds the Introduction of Bipartisan Legislation to Reduce Drug Costs and Support Medication Access for Seniors with Life-Threatening Specialized Conditions May 27, 2021 This week, a bipartisan group of lawmakers in the U.S. House and Senate introduced legislation to rein in the high cost of prescription drugs and support the needs of specialty pharmacy patients living with life-altering and life-threatening specialty medical conditions. read more
- NASP Comments on CMS Most Favored Nation (MFN) Model Interim Final Rule (CMS-5528-IFC) Feb 18, 2021 The National Association of Specialty Pharmacy (NASP) submitted comments on the Center for Medicare and Medicaid... read more
- Pharmaceutical Supply and Payment Chain Coalition Letter to President Biden Jan 21, 2021 On January 14, 2021 the National Association of Specialty Pharmacy (NASP) in part of the Pharmaceutical... read more
- NASP Comments on the proposed rule: “Medicare Program; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Policy Issues and Level II of the Healthcare Common Procedure Coding System (HCPCS)” Jan 05, 2021 The National Association of Specialty Pharmacy (NASP) is pleased to provide comments in response to proposed... read more
- NASP Comments on Health and Human Services (HHS) Request for Information (RFI) on Regulatory Relief to Support Economic Recovery Dec 28, 2020 The National Association of Specialty Pharmacy (NASP) is pleased to provide comments in response to the... read more